In one of the most promising clinical trials in the field of allergy treatment, researchers from King's College London, in collaboration with Guy’s and St Thomas’ NHS Foundation Trust, conducted a pioneering study to treat peanut allergy in adults. This trial, named Grown Up Peanut Immunotherapy (GUPI), marks a major breakthrough in addressing one of the most widespread and severe food allergies.
The study targeted a small group of 21 adults aged between 18 and 40, all of whom suffered from severe peanut allergies. Instead of avoiding the allergen as is the common practice as the therapeutic protocol relied on oral immunotherapy, gradually exposing the participants to increasing doses of peanut protein. They began by ingesting less than one-hundredth of a single peanut and, under strict medical supervision over several months, the dosage was progressively increased.
By the end of the trial, 67% of participants were able to consume the equivalent of five peanuts daily without experiencing any allergic reaction a significant achievement considering that even minimal exposure had previously posed a serious threat to their lives. Moreover, results showed a 100-fold increase in their clinical threshold, meaning their sensitivity to peanuts had drastically diminished.
The improvement wasn’t limited to physical tolerance. Most participants reported a marked enhancement in their quality of life, with reduced anxiety about dining out or accidental exposure factors that had significantly impacted their daily routines. Notably, the treatment protocol did not involve any adjunctive medications such as omalizumab, relying solely on the gradual desensitization approach.
This trial represents a crucial step toward expanding food allergy treatment options for adults, a group often overlooked due to the challenges of modifying immune responses later in life. The scientific community has called for more research in this area, especially since peanut allergy remains one of the leading causes of life-threatening allergic reactions in the Western world.
In light of these results, researchers are hopeful that this form of therapy will soon be incorporated into standard medical practices, with more comprehensive and safer protocols that could pave the way for treating other food allergies using the same method.
Source: https://www.thetimes.com/
